Xometry, Inc. $XMTR Position Trimmed by Vitruvian Partners LLP

Vitruvian Partners LLP lessened its holdings in shares of Xometry, Inc. (NASDAQ:XMTR) by 18.6% during the 4th quarter, HoldingsChannel reports. The fund owned 191,919 shares of the company’s stock after selling 43,741 shares during the period. Xometry accounts for approximately 8.2% of Vitruvian Partners LLP’s portfolio, making the stock its 4th biggest holding. Vitruvian Partners LLP’s holdings in Xometry were worth $11,413,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Quantbot Technologies LP purchased a new position in Xometry during the 3rd quarter valued at about $30,000. GAMMA Investing LLC grew its stake in shares of Xometry by 26.5% in the 4th quarter. GAMMA Investing LLC now owns 773 shares of the company’s stock valued at $46,000 after buying an additional 162 shares in the last quarter. Leonteq Securities AG bought a new stake in shares of Xometry in the 4th quarter valued at approximately $59,000. Comerica Bank grew its stake in shares of Xometry by 17.9% in the 3rd quarter. Comerica Bank now owns 1,140 shares of the company’s stock valued at $62,000 after buying an additional 173 shares in the last quarter. Finally, PNC Financial Services Group Inc. grew its stake in shares of Xometry by 283.7% in the 3rd quarter. PNC Financial Services Group Inc. now owns 1,508 shares of the company’s stock valued at $82,000 after buying an additional 1,115 shares in the last quarter. Hedge funds and other institutional investors own 97.31% of the company’s stock.

Analyst Upgrades and Downgrades

XMTR has been the subject of several recent research reports. Cantor Fitzgerald raised Xometry from a “neutral” rating to an “overweight” rating and set a $62.00 price target for the company in a research note on Thursday, April 30th. Citizens Jmp boosted their price target on Xometry from $75.00 to $100.00 and gave the company a “market outperform” rating in a research note on Friday, May 8th. William Blair reissued an “outperform” rating on shares of Xometry in a research note on Tuesday, February 24th. Royal Bank Of Canada boosted their price target on Xometry from $55.00 to $85.00 and gave the company a “sector perform” rating in a research note on Friday, May 8th. Finally, Wedbush lowered their price target on Xometry from $70.00 to $60.00 and set an “outperform” rating for the company in a research note on Wednesday, February 25th. Six analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the stock has an average rating of “Hold” and an average price target of $76.00.

Xometry Stock Up 2.7%

Shares of Xometry stock opened at $89.21 on Friday. The stock has a market capitalization of $4.62 billion, a P/E ratio of -87.46 and a beta of 1.01. The company has a quick ratio of 1.76, a current ratio of 1.78 and a debt-to-equity ratio of 0.86. The stock has a 50 day moving average price of $53.71 and a two-hundred day moving average price of $56.92. Xometry, Inc. has a 12-month low of $29.60 and a 12-month high of $93.13.

Xometry (NASDAQ:XMTR) last announced its earnings results on Thursday, May 7th. The company reported $0.12 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.07 by $0.05. The firm had revenue of $205.14 million during the quarter, compared to analysts’ expectations of $188.46 million. Xometry had a negative return on equity of 4.37% and a negative net margin of 7.01%.The company’s revenue was up 35.9% on a year-over-year basis. During the same quarter in the prior year, the business earned ($0.05) earnings per share. Equities analysts expect that Xometry, Inc. will post -0.11 earnings per share for the current year.

Insider Activity

In related news, Director Katharine Weymouth bought 1,215 shares of the firm’s stock in a transaction on Friday, February 27th. The stock was purchased at an average price of $41.15 per share, with a total value of $49,997.25. Following the completion of the transaction, the director directly owned 3,615 shares of the company’s stock, valued at $148,757.25. This trade represents a 50.63% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Emily Rollins sold 1,000 shares of the company’s stock in a transaction that occurred on Wednesday, April 1st. The stock was sold at an average price of $42.02, for a total value of $42,020.00. Following the sale, the director directly owned 15,136 shares of the company’s stock, valued at $636,014.72. The trade was a 6.20% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders have sold 128,934 shares of company stock valued at $8,387,014. Insiders own 9.10% of the company’s stock.

Xometry Company Profile

Xometry, Inc (NASDAQ: XMTR) operates a technology-driven marketplace that connects businesses with on-demand manufacturing capacity across a wide array of processes. Through its proprietary Instant Quoting Engine and Xometry Platform, the company streamlines sourcing for CNC machining, 3D printing, sheet metal fabrication, injection molding, urethane casting and other custom manufacturing services. By aggregating a network of thousands of vetted suppliers, Xometry offers rapid lead times, transparent pricing and real-time order tracking to customers in sectors ranging from automotive and aerospace to medical devices and industrial equipment.

Since its founding in 2013 and headquarters in Rockville, Maryland, Xometry has expanded its geographic reach to serve customers in North America, Europe and beyond.